Columbia, MO, United States of America

Nagavara Kishore Pillarsetty

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Nagavara Kishore Pillarsetty

Introduction

Nagavara Kishore Pillarsetty is an accomplished inventor based in Columbia, MO (US). He has made significant contributions to the field of radiopharmaceuticals through his innovative work. His research focuses on the design and development of site-specific biomolecule conjugation strategies.

Latest Patents

Pillarsetty holds a patent for a bifunctional chelating agent that enhances the labeling of biomolecules with transition metals or radiometals. This method allows for the production of diagnostic or therapeutic pharmaceutical compounds. The patent outlines a process that involves synthesizing a P N-bifunctional chelating agent intermediate, complexing it with a metal, and covalently linking it to a biomolecule in a site-specific manner. This innovative approach has the potential to improve the efficacy of therapeutic and diagnostic agents.

Career Highlights

Pillarsetty is affiliated with the University of Missouri, where he continues to advance his research in the field of radiopharmaceuticals. His work has garnered attention for its potential applications in medicine and diagnostics. He has successfully developed methods that could lead to more effective treatments for various diseases.

Collaborations

Pillarsetty has collaborated with notable colleagues, including Kattesh V Katti and Kandikere R Prabhu. These partnerships have contributed to the advancement of his research and the development of innovative solutions in the field.

Conclusion

Nagavara Kishore Pillarsetty's contributions to the field of radiopharmaceuticals through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the development of diagnostic and therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…